GBI Research, a leading business intelligence provider, has released its latest research report, "Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth". The asthma market is forecast to grow marginally over the forecast period across the leading eight developed nations, from $16.6 billion in 2012 to a projected value of $21.6 billion in 2019.
The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. This is in spite of generic erosion facing several of the leading asthma brands, such as Advair (fluticasone propionate/salmeterol xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), and is a consequence of new market entrants and rising disease prevalence.
The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. See Full Report: http://goo.gl/6R29xF
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma.
Asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape.
GBI Research, a leading business intelligence provider, has released its latest research report, Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations. The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%. Enquiry @ http://www.researchbeam.com/asthma-therapeutics-in-major-developed-to-2020-personalized-treatment-for-severe-asthma-to-drive-growth-despite-patent-expirations-market/enquire-about-report
Asthma Therapeutics Market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 2.4%.
"Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patterns", which provides in-depth analysis of epilepsy market within the eight major developed markets of the US, UK, France, Germany, Italy, Spain, Japan and Canada.
Big Market Research “Asthma Drugs Market in the US” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/asthma-drugs-in-the-us-2015-2019-market Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
GBI Research, the leading business intelligence provider, has released its latest research, Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth, which provides insights into psoriasis therapeutics in the Asia-Pacific (APAC) market. Detailed Report at: http://www.reportsandintelligence.com/psoriasis-therapeutics-in-asia-pacific-to-2021-advent-of-novel-biologics-and-expanding-treatment-pool-to-drive-growth-market
Big Market Research, PharmaPoint: Global Asthma Drug Market Size, Share, Strategies, Trends, Application, Forecast, Demand, Analysis, Research, Report, Opportunities. Big Market Research added a new research report "PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023". Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade. The largest unmet needs mainly reflect the high level of heterogeneity of the disease, the lack of patient compliance with the standard therapies, and the high cost of medications for asthma treatment. In addition, there is a lack of diagnostic tools to provide a reliable diagnosis of asthma in young children. Annualized asthma therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2013 and forecast for ten years to 2023.
Global lower respiratory tract therapeutics market size is expected to reach $48.37 Bn by 2028 at a rate of 7.8%, segmented as by disease type, asthma, chronic obstructive pulmonary disease, pneumonia, tuberculosis, bronchitis, other diseases
The report "Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021", The global digital therapeutics market is expected to reach USD 457.9 Million by 2021 from USD 110 Million in 2016, growing at a CAGR of 27.7% from 2016 to 2021.
Big Market Research adds a report “Asthma Therapeutics Industry- Size, Share, Trends, Forecast, Growth, Opportunities, Outlook " Get Complete Report @ http://www.bigmarketresearch.com/global-asthma-therapeutics-industry-2015-research-report-market 2015 Global Asthma Therapeutics Industry Report is a professional and in-depth research report on the worlds major regional market conditions of the Asthma Therapeutics industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). Enquire about this report @ http://www.bigmarketresearch.com/report-enquiry/367423
Research Beam added report on "Global Asthma Therapeutics Industry Development, Size, Share, Trends, Segmentation, Growth, Technology, Opportunity, Analysis and Forecast 2015" Enquiry about report: http://www.researchbeam.com/global-asthma-therapeutics-industry-2015-deep-research-report-market/enquire-about-report
Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD).
BlueWeave Consulting review study of the Respiratory Care Devices Market reached to US$ 18,714 million in 2018, anticipated to propel to US$27,063 million by 2025 with a significant CAGR of over 8% in the forecast period of 2019-2025.
Download sample brochure @ http://tinyurl.com/jeu5bak This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.
Asthma accounts for approximately 250,000 deaths around the world annually, deaths that otherwise could be easily prevented through appropriate treatment The asthma market saw very slow growth over the past decade, as it has become saturated with relatively efficacious standard therapies, such as short-acting beta-agonists (SABAs), inhaled corticosteroids (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and has also been facing increasing generic competition. See Full Report @ bit.ly/12yBegp
The global video doorbell market size is expected to reach USD 5.74 Billion by 2028 and register a CAGR of 17.3%, according to the latest report by Emergen Research. Key factors such as rising adoption of Artificial Intelligence (AI), rapid growth in digitalization, and increasing need for deployment of video doorbells are driving global market revenue growth. A video doorbell also called a doorbell camera is an outdoor camera installed on the front door of the house and is connected to smartphones or other electronic devices via internet. Video doorbell notifies the owner about the guest or person present at the doorstep.
The global mass spectrometry market size reached USD 4.36 Billion in 2021 and is expected to register a revenue CAGR of 6.1% during the forecast period, according to latest analysis by Emergen Research. Increased spending by pharmaceutical companies on research & development activities is a major factor driving market revenue growth. These research activities are also facilitating developments and drawing in investments in biopharmaceutical and personalized medicine.
The global Wi-Fi 6 devices market size is expected to reach USD 27.42 Billion in 2028, and register a CAGR of 25.1% during the forecast period. Market revenue growth is primarily driven by rising demand for high-speed wireless connectivity owing to benefits of instant network traffic routing offered by Wi-Fi 6. These devices are effective for even remote devices in crowded networks. Wi-Fi 6 provides reliable connectivity solutions, to a very large network traffic volume, thereby allowing for higher number of smartphones, laptops, cameras, displays, smart speakers, and other Internet of Things (IoT) and personal devices to be seamlessly connected and communicate with each other.
Allergies are hypersensitive responses by the human immune system to the substances that come in contact with the body. Some stimuli that cause an allergic reaction are dust mites, animal dander, cockroaches, pollens, mold, food substances, metals, elements, and more.
According to a new market research study titled ‘Digital Therapeutics Market to 2025 – Global Analysis and Forecasts by Application and Distribution Channel, the global digital therapeutics market was valued at US$ 1,993.2 Mn in 2017 and is estimated to reach US$ 8,941.1 Mn by 2025. The market is estimated to grow with a CAGR of 20.8% from 2018-2025. The report highlights the trends prevalent in the global digital therapeutics market and the factors driving the market along with those that act as deterrents to its growth. Download Sample Copy at http://bit.ly/2OmqZbn
TBRC global oral biologics and biosimilars market report includes lymphocyte modulators, interleukin inhibitors, and tumor necrosis factor-alpha inhibitors
Some of the players identified in the Home Respiratory Therapy Market include: Genesis Rehab Services West River Health Services Fisher & Paykel Healthcare Limited Medtronic plc Dräger Safety AG & Co. KGaA
TBRC published a new research report on “Biosimilar Interleukins Market Insights, to 2025" with new evolving trends, drivers, restraints, opportunities. https://bit.ly/39VWLVh
Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
A recent report published by The Business Research Company on Biosimilar Interleukins Market provides in-depth analysis of segments and sub-segments in the global as well as regional. https://bit.ly/3nk0W25
Looking forward, the alpha 1 antitrypsin feficiency treatment market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/alpha-1-antitrypsin-deficiency-treatment-market
Pneumonia Therapeutics Market Size is expected to exceed USD 2.8 Bn by 2026. Increasing government initiatives for the treatment of pneumonia will significantly accelerate the overall business progression. Request sample copy of this Report @ https://www.gminsights.com/request-sample/detail/2029
Global Prescription digital therapeutics (DTx) market is rising gradually with a healthy CAGR of 23.35% in the forecast period of 2019-2026. Growing prevalence of cancer worldwide and expanding the application of CRISPR technology by innovative research from the different academic organizations are the key factors for market growth.
The major players covered in the global oral biologics & biosimilar drugs market are Novartis, Rani Therapeutics, Eli Lilly and Co., AstraZeneca plc, Novo Nordisk A/S.... @ @ https://bit.ly/3gz5Nve
GBI Research, the leading business intelligence provider, has released its latest research, Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 Increasing Uptake of Novel Drug Classes to Drive Market Growth, which provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan and Australia. The report estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. It also provides in-depth analysis of the pipeline molecules, clinical trial failure rates, and recent deals. The report has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis carried out by GBI Research’s team of industry experts. View full report with TOC: http://www.reportsandintelligence.com/digest-aesthetic-lasers-and-energy-devices-2006-to-2020-asia-pacific-market
According to MRFR Analysis – silent heart market is growing at a CAGR of 5.7% during the forecast period 2017 to 2023. The global market industry categorizes by type, indication, devices, end user, and region.
Global Cytokine Release Syndrome Drug Market to grow with substantial CAGR in the forecast period of 2019-2026. Rising number of patients who have treated by immunotherapy and Government initiative in research and development for more available novel therapies for the treatment of cytokine release syndrome are key factor for enhancing the market growth.
“Pharmaceutical Market: India, A Competitive Industry Analysis Q3 2013” by Kelly Scientific Publications is a comprehensive report on the pharmaceutical and biotechnology industry in India and its impact on international markets. See Full Report @ http://bit.ly/1zVmJyK
During the forecast period from 2012 - 2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnsons (J&Js) Simponi and Takedas Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada.
Big Market Research : World Anti-Inflammatory Therapeutics Market - Size, Share, Trends, Demand, Report, Opportunities and Forecast 2020 To Get More Details @ http://www.bigmarketresearch.com/anti-inflammatory-therapeutic-market Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks to eliminate the cause of injury, clear dead and necrotic cells and heal injured tissues. Sometimes, the body defense system inappropriately triggers inflammation against its own cells, resulting in incurable inflammatory autoimmune diseases such as arthritis, asthma and chronic obstructive pulmonary disease (COPD). According to World Health Organization (WHO), approximately 235 million people suffer from asthma in the world.
Internet of things (IoT), comprising components such as devices, network connectivity, electronics system and software, is basically the networking of connected devices or things to transmit the data between them without human intervention Check complete report @ http://www.marketintelreports.com/report/allied0107/world-internet-of-things-in-healthcare-market--opportunities-and-forecasts-2014-2021
The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope.
The global respiratory care devices market was valued at USD 21.00 billion in 2018. Rising prevalence of COPD, asthma and other respiratory disorders on account of increasing pollution across various countries is likely to fuel the market growth in coming years.
Increase in prevalence of target diseases including diabetes, asthma, chronic obstructive pulmonary disorder (COPD), and cardiovascular diseases coupled with rapid technological advancements in drug delivery devices are key factors driving the global electronic drug delivery systems market.
This research report titled “Global Respiratory Care Medical Devices Market: Size, Trends & Forecasts (2018-2022)”, provides an in-depth analysis of the global respiratory care medical devices market with description of market sizing and growth. The analysis includes market by value and market share by region, by product-type, and by disorders. An analysis of product analysis has also been provided in the report. Complete report on Respiratory Care Medical Devices market spread across 77 pages with providing 4 company profiles, 2 tables and 33 figures is now available at http://www.marketreportsonline.com/781837.html.